A detailed history of Soleus Capital Management, L.P. transactions in Surmodics Inc stock. As of the latest transaction made, Soleus Capital Management, L.P. holds 637,698 shares of SRDX stock, worth $25.3 Million. This represents 2.1% of its overall portfolio holdings.

Number of Shares
637,698
Previous 781,777 18.43%
Holding current value
$25.3 Million
Previous $32.9 Million 24.76%
% of portfolio
2.1%
Previous 3.33%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$38.47 - $42.24 $5.54 Million - $6.09 Million
-144,079 Reduced 18.43%
637,698 $24.7 Million
Q2 2024

Aug 14, 2024

SELL
$25.39 - $42.1 $483,501 - $801,710
-19,043 Reduced 2.38%
781,777 $32.9 Million
Q1 2024

May 15, 2024

BUY
$27.44 - $35.56 $799,052 - $1.04 Million
29,120 Added 3.77%
800,820 $23.5 Million
Q4 2023

Feb 14, 2024

SELL
$28.47 - $38.49 $13.1 Million - $17.7 Million
-459,162 Reduced 37.3%
771,700 $28.1 Million
Q3 2023

Nov 14, 2023

SELL
$28.28 - $38.36 $3 Million - $4.07 Million
-105,976 Reduced 7.93%
1,230,862 $39.5 Million
Q2 2023

Aug 14, 2023

BUY
$17.67 - $31.31 $7.85 Million - $13.9 Million
444,160 Added 49.76%
1,336,838 $41.9 Million
Q1 2023

May 15, 2023

BUY
$17.13 - $38.52 $2.01 Million - $4.52 Million
117,367 Added 15.14%
892,678 $20.3 Million
Q4 2022

Feb 14, 2023

BUY
$29.44 - $37.31 $201,163 - $254,939
6,833 Added 0.89%
775,311 $26.5 Million
Q3 2022

Nov 14, 2022

BUY
$28.84 - $38.92 $3.1 Million - $4.18 Million
107,474 Added 16.26%
768,478 $23.4 Million
Q2 2022

Aug 15, 2022

BUY
$33.25 - $45.11 $3.41 Million - $4.63 Million
102,564 Added 18.37%
661,004 $24.6 Million
Q1 2022

May 16, 2022

BUY
$40.68 - $49.72 $1.04 Million - $1.28 Million
25,683 Added 4.82%
558,440 $25.3 Million
Q4 2021

Feb 14, 2022

BUY
$43.21 - $57.6 $6.53 Million - $8.71 Million
151,235 Added 39.64%
532,757 $25.7 Million
Q3 2021

Nov 15, 2021

BUY
$52.8 - $60.32 $5.44 Million - $6.22 Million
103,118 Added 37.04%
381,522 $21.2 Million
Q2 2021

Aug 16, 2021

BUY
$51.29 - $59.15 $6.37 Million - $7.34 Million
124,129 Added 80.46%
278,404 $15.1 Million
Q1 2021

May 17, 2021

BUY
$42.18 - $56.07 $2.59 Million - $3.44 Million
61,300 Added 65.93%
154,275 $8.65 Million
Q4 2020

Feb 16, 2021

BUY
$35.18 - $43.52 $552,044 - $682,915
15,692 Added 20.3%
92,975 $4.05 Million
Q3 2020

Nov 13, 2020

BUY
$37.98 - $48.72 $1.26 Million - $1.62 Million
33,305 Added 75.73%
77,283 $3.01 Million
Q2 2020

Aug 14, 2020

BUY
$31.07 - $44.74 $1.37 Million - $1.97 Million
43,978 New
43,978 $1.9 Million

Others Institutions Holding SRDX

About SURMODICS INC


  • Ticker SRDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 14,005,000
  • Market Cap $557M
  • Description
  • Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...
More about SRDX
Track This Portfolio

Track Soleus Capital Management, L.P. Portfolio

Follow Soleus Capital Management, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Soleus Capital Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Soleus Capital Management, L.P. with notifications on news.